Prevention and treatment of HIV and other sexually transmitted infections among MSM and transgender people Recommendations for a public health approach 2011

Published: July 1, 2011

TABLE OF CONTENTS

Acronyms and abbreviations
Acknowledgements
Funding and declarations of interest
Executive summary
1. Background
2. Scope of the guidelines
3. Guiding principles
4. Objectives and target audience
5. Methodology and process
5.1 Grade framework
5.2 Process
6. Adapting the guidelines
7. Good practice recommendations
8. Evidence and technical recommendations
8.1. Prevention of sexual transmission
8.1.1. Consistent condom use
8.1.2. Serosorting
8.1.3. Male circumcision
8.2. HIV testing and counselling
8.2.1. HIV testing and counselling
8.2.2. Community-based hiv testing and counselling linked to care
and treatment
8.3. Behavioural interventions and information, education, communication
8.3.1. Individual-level behavioural interventions for the prevention of
HIV infection
8.3.2. Community-level behavioural interventions for the prevention
of HIV infection
8.3.3. Targeted internet-based strategies
8.3.4. Social marketing-based strategies
8.3.5. Sex venue-based outreach strategies
8.4. Substance use, prevention of bloodborne infections
8.4.1. Mental health interventions for substance use
8.4.2. Harm reduction for injecting drug use
8.4.3. Safe injections for transgender people who use
gender-enhancement procedures
8.5. HIV care and treatment
8.5.1. Antiretroviral therapy for msm and transgender people living
with HIV
8.5.2. Other prevention and care interventions for msm and
transgender people living with HIV
8.6. Prevention and care of other sexually transmitted infections
8.6.1. Syndromic management of sexually transmitted infections
8.6.2. Periodic testing for asymptomatic forms of urethral and rectal
N. gonorrhoeae infection using (1) naat and (2) culture; and
periodic testing for asymptomatic forms of urethral and rectal
C. trachomatis infection using naat
8.6.3. Periodic testing for asymptomatic syphilis infection
8.6.4. Hepatitis b vaccination
8.7. Note on oral hiv pre-exposure prophylaxis

References

Leave a Reply